Two of these ligands (ALCAM and VLA‐4) are particularly highly expressed in tumour cells, and the neutralisation of either ligand with antibodies has been found to significantly reduce tumour seeding in the brain.11, 12. The gene discussed is ALCAM; the disease is neoplasm.